A complication of the infusaid pump: Duodenal atony reversed by urecholine

The totally implantable infusion pump (Infusaid pump) for treating metastatic disease to the liver is a new treatment that is gaining widespread acceptance. However, as might be expected for any new major surgical procedure, there are increasing reports of complications. We report a complication in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of surgical oncology 1987-11, Vol.36 (3), p.210-214
Hauptverfasser:	Silberman, Allan W., Rosenkranz, Eliot, Kosakowski, Christopher, Chervu, Arun, Sugasawara, Roy I., Ramming, Kenneth P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bethanechol Compounds - therapeutic use Biological and medical sciences Drug toxicity and drugs side effects treatment Duodenal Obstruction - drug therapy Duodenal Obstruction - etiology Duodenum - pathology Duodenum - physiopathology Floxuridine - administration & dosage Floxuridine - adverse effects FUDR Gastrointestinal Motility Humans Infusaid pump Infusion Pumps - adverse effects liver Liver Neoplasms - drug therapy Liver Neoplasms - secondary Male Medical sciences metastatic disease Middle Aged Pharmacology. Drug treatments Tissue Adhesions - etiology Tissue Adhesions - pathology Toxicity: digestive system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The totally implantable infusion pump (Infusaid pump) for treating metastatic disease to the liver is a new treatment that is gaining widespread acceptance. However, as might be expected for any new major surgical procedure, there are increasing reports of complications. We report a complication in which duodenal atony was caused by the infusion of the chemotherapeutic agent (FUDR) into the stomach and duodenum. The atony was totally reversed by the subcutaneous administration of Urecholine.
ISSN:	0022-4790 1096-9098
DOI:	10.1002/jso.2930360312